Davita Inc  

(Public, NYSE:DVA)   Watch this stock  
Find more results for dva
-0.13 (-0.18%)
Feb 16 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 73.16 - 74.51
52 week 52.51 - 80.71
Open 73.81
Vol / Avg. 1.30M/1.47M
Mkt cap 13.50B
P/E 15.19
Div/yield     -
EPS 4.85
Shares 182.46M
Beta 0.99
Inst. own 87%
Apr 30, 2018
Q1 2018 DaVita Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Feb 13, 2018
Q4 2017 DaVita Inc Earnings Release
Jan 10, 2018
DaVita Inc at JPMorgan Healthcare Conference - Q&A Session
Jan 10, 2018
DaVita Inc at JPMorgan Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin 7.09% 9.89%
Operating margin 5.41% 16.67%
EBITD margin - 22.04%
Return on average assets 4.16% 5.71%
Return on average equity 13.53% 19.47%
Employees 70,300 -
CDP Score - -


2000 16th St
DENVER, CO 80202-5158
United States - Map
+1-310-5362668 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


DaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.

Officers and directors

Kent J. Thiry Chairman of the Board
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James K. Hilger Interim Chief Financial Officer, Chief Accounting Officer
Age: 55
Bio & Compensation  - Reuters
Joel Ackerman Chief Financial Officer
Age: 51
Bio & Compensation  - Reuters
Robert Lang President, International Business
Bio & Compensation  - Reuters
Javier J. Rodriguez Chief Executive Officer - Kidney Care
Age: 46
Bio & Compensation  - Reuters
Jeanine M. Jiganti Chief Compliance Officer
Age: 57
Bio & Compensation  - Reuters
LeAnne M. Zumwalt Group Vice President - purchasing and government affairs
Age: 58
Bio & Compensation  - Reuters
Kathleen Alyce Waters Chief Legal Officer
Age: 49
Bio & Compensation  - Reuters
Peter T. Grauer Lead Director, Independent Director
Age: 71
Bio & Compensation  - Reuters
Pamela M. Arway Independent Director
Age: 63
Bio & Compensation  - Reuters